Advertisement
Australia markets closed
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • AUD/USD

    0.6507
    +0.0007 (+0.11%)
     
  • OIL

    82.74
    -0.07 (-0.08%)
     
  • GOLD

    2,331.60
    -6.80 (-0.29%)
     
  • Bitcoin AUD

    98,766.20
    -3,757.82 (-3.67%)
     
  • CMC Crypto 200

    1,383.09
    -41.01 (-2.87%)
     
  • AUD/EUR

    0.6076
    +0.0006 (+0.10%)
     
  • AUD/NZD

    1.0950
    +0.0008 (+0.07%)
     
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     
  • FTSE

    8,040.38
    -4.43 (-0.06%)
     
  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     
  • DAX

    18,088.70
    -48.95 (-0.27%)
     
  • Hang Seng

    17,272.33
    +71.06 (+0.41%)
     
  • NIKKEI 225

    37,778.88
    -681.20 (-1.77%)
     

If You Invested $10,000 in Regeneron Pharmaceuticals 5 Years Ago, This Is How Much You Would Have Today

If You Invested $10,000 in Regeneron Pharmaceuticals 5 Years Ago, This Is How Much You Would Have Today

Regeneron Pharmaceuticals (NASDAQ: REGN) has been a reliable, steadily growing stock over the years, with the top line and profits increasing. Below, I'll look at just how well the stock has performed over the past five years and whether Regeneron is a good buy moving forward. In early August 2017, shares of Regeneron were trading at around $470 per share.